[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific RNA Drugs Market Report 2017

August 2017 | 115 pages | ID: A8163A41023EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific RNA Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific RNA Drugs market competition by top manufacturers/players, with RNA Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Abbott Laboratories
  • Arrowhead Pharmaceuticals
  • Benitec Biopharma
  • Calimmune Inc
  • Dicerna
  • Gradalis
  • Quark
  • RXi
  • Senesco
  • Silence Therapeutics
  • Silenseed
  • Tekmira
  • Alnylam Pharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • siRNA
  • ASO
  • miRNA
  • Nucleic Acid Aptamers
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of RNA Drugs for each application, includin
  • Cancer
  • Diabetes
  • Tuberculosis
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific RNA Drugs Market Report 2017

1 RNA DRUGS OVERVIEW

1.1 Product Overview and Scope of RNA Drugs
1.2 Classification of RNA Drugs by Product Category
  1.2.1 Asia-Pacific RNA Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific RNA Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 siRNA
  1.2.4 ASO
  1.2.5 miRNA
  1.2.6 Nucleic Acid Aptamers
1.3 Asia-Pacific RNA Drugs Market by Application/End Users
  1.3.1 Asia-Pacific RNA Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Asia-Pacific RNA Drugs Market by Region
  1.4.1 Asia-Pacific RNA Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of RNA Drugs (2012-2022)
  1.5.1 Asia-Pacific RNA Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific RNA Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC RNA DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific RNA Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific RNA Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific RNA Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific RNA Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific RNA Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific RNA Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific RNA Drugs (Volume) by Application
2.4 Asia-Pacific RNA Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific RNA Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific RNA Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China RNA Drugs Sales and Value (2012-2017)
  3.1.1 China RNA Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China RNA Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China RNA Drugs Sales Price Trend (2012-2017)
3.2 China RNA Drugs Sales Volume and Market Share by Type
3.3 China RNA Drugs Sales Volume and Market Share by Application

4 JAPAN RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan RNA Drugs Sales and Value (2012-2017)
  4.1.1 Japan RNA Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan RNA Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan RNA Drugs Sales Price Trend (2012-2017)
4.2 Japan RNA Drugs Sales Volume and Market Share by Type
4.3 Japan RNA Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea RNA Drugs Sales and Value (2012-2017)
  5.1.1 South Korea RNA Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea RNA Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea RNA Drugs Sales Price Trend (2012-2017)
5.2 South Korea RNA Drugs Sales Volume and Market Share by Type
5.3 South Korea RNA Drugs Sales Volume and Market Share by Application

6 TAIWAN RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan RNA Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan RNA Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan RNA Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan RNA Drugs Sales Price Trend (2012-2017)
6.2 Taiwan RNA Drugs Sales Volume and Market Share by Type
6.3 Taiwan RNA Drugs Sales Volume and Market Share by Application

7 INDIA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India RNA Drugs Sales and Value (2012-2017)
  7.1.1 India RNA Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India RNA Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India RNA Drugs Sales Price Trend (2012-2017)
7.2 India RNA Drugs Sales Volume and Market Share by Type
7.3 India RNA Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia RNA Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia RNA Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia RNA Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia RNA Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia RNA Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia RNA Drugs Sales Volume and Market Share by Application

9 AUSTRALIA RNA DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia RNA Drugs Sales and Value (2012-2017)
  9.1.1 Australia RNA Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia RNA Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia RNA Drugs Sales Price Trend (2012-2017)
9.2 Australia RNA Drugs Sales Volume and Market Share by Type
9.3 Australia RNA Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC RNA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 RNA Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 RNA Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Sanofi-Aventis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 RNA Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 RNA Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Arrowhead Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 RNA Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Benitec Biopharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 RNA Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Calimmune Inc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 RNA Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Dicerna
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 RNA Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Gradalis
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 RNA Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Quark
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 RNA Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 RXi
10.12 Senesco
10.13 Silence Therapeutics
10.14 Silenseed
10.15 Tekmira
10.16 Alnylam Pharmaceuticals

11 RNA DRUGS MANUFACTURING COST ANALYSIS

11.1 RNA Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNA Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 RNA Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNA Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RNA DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific RNA Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific RNA Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific RNA Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific RNA Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific RNA Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific RNA Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific RNA Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia RNA Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific RNA Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific RNA Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific RNA Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific RNA Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific RNA Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA Drugs
Figure Asia-Pacific RNA Drugs Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific RNA Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure siRNA Product Picture
Figure ASO Product Picture
Figure miRNA Product Picture
Figure Nucleic Acid Aptamers Product Picture
Figure Asia-Pacific RNA Drugs Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of RNA Drugs by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific RNA Drugs Market Size (Million USD) by Region (2012-2022)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific RNA Drugs Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific RNA Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific RNA Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific RNA Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific RNA Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific RNA Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific RNA Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific RNA Drugs Revenue Share by Players
Figure 2017 Asia-Pacific RNA Drugs Revenue Share by Players
Table Asia-Pacific RNA Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific RNA Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of RNA Drugs by Type (2012-2017)
Figure Asia-Pacific RNA Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific RNA Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA Drugs by Type (2012-2017)
Figure Asia-Pacific RNA Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific RNA Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA Drugs by Region (2012-2017)
Figure Asia-Pacific RNA Drugs Sales Market Share by Region in 2016
Table Asia-Pacific RNA Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific RNA Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of RNA Drugs by Region (2012-2017)
Figure Asia-Pacific RNA Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific RNA Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific RNA Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific RNA Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific RNA Drugs Sales Market Share by Application (2012-2017)
Figure China RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table China RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure China RNA Drugs Sales Volume Market Share by Type in 2016
Table China RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table China RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure China RNA Drugs Sales Volume Market Share by Application in 2016
Figure Japan RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan RNA Drugs Sales Volume Market Share by Type in 2016
Table Japan RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Japan RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan RNA Drugs Sales Volume Market Share by Application in 2016
Figure South Korea RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table South Korea RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea RNA Drugs Sales Volume Market Share by Type in 2016
Table South Korea RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table South Korea RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea RNA Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Taiwan RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan RNA Drugs Sales Volume Market Share by Type in 2016
Table Taiwan RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan RNA Drugs Sales Volume Market Share by Application in 2016
Figure India RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table India RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure India RNA Drugs Sales Volume Market Share by Type in 2016
Table India RNA Drugs Sales Volume (K Units) by Application (2012-2017)
Table India RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure India RNA Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia RNA Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia RNA Drugs Sales Volume Market Share by Application in 2016
Figure Australia RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia RNA Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia RNA Drugs Sales Volume (K Units) by Type (2012-2017)
Table Australia RNA Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia RNA Drugs Sales Volume Market Share by Type in 2016
Table Australia RNA Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Australia RNA Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia RNA Drugs Sales Volume Market Share by Application in 2016
Table Pfizer RNA Drugs Basic Information List
Table Pfizer RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche RNA Drugs Basic Information List
Table Roche RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Roche RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi-Aventis RNA Drugs Basic Information List
Table Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi-Aventis RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories RNA Drugs Basic Information List
Table Abbott Laboratories RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Arrowhead Pharmaceuticals RNA Drugs Basic Information List
Table Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Benitec Biopharma RNA Drugs Basic Information List
Table Benitec Biopharma RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benitec Biopharma RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Benitec Biopharma RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Calimmune Inc RNA Drugs Basic Information List
Table Calimmune Inc RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Calimmune Inc RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Calimmune Inc RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Dicerna RNA Drugs Basic Information List
Table Dicerna RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Dicerna RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Dicerna RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Gradalis RNA Drugs Basic Information List
Table Gradalis RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Gradalis RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Gradalis RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Quark RNA Drugs Basic Information List
Table Quark RNA Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Quark RNA Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Quark RNA Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table RXi RNA Drugs Basic Information List
Table Senesco RNA Drugs Basic Information List
Table Silence Therapeutics RNA Drugs Basic Information List
Table Silenseed RNA Drugs Basic Information List
Table Tekmira RNA Drugs Basic Information List
Table Alnylam Pharmaceuticals RNA Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Drugs
Figure Manufacturing Process Analysis of RNA Drugs
Figure RNA Drugs Industrial Chain Analysis
Table Raw Materials Sources of RNA Drugs Major Manufacturers in 2016
Table Major Buyers of RNA Drugs
Table Distributors/Traders List
Figure Asia-Pacific RNA Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific RNA Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific RNA Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific RNA Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific RNA Drugs Revenue Market Share Forecast by Region in 2022
Figure China RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia RNA Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific RNA Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific RNA Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific RNA Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific RNA Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific RNA Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories